Certificate No.: H-2024-1362 Validity: April 18, 2024 to April 17, 2028
See our Health Check-up Packages
See our Radiology Tests Services.
The Department of Nuclear Medicine at JNU Hospital is a state-of-the-art facility dedicated to providing advanced diagnostic and therapeutic services to patients.
We specialize in molecular imaging techniques that allow early and accurate detection of diseases, enabling timely treatment. Currently, our department is equipped with a GE discoveryIQ PET-CT scanner Gen-2, which combines Positron Emission Tomography (PET) and Computed Tomography (CT) to provide precise imaging for oncology, neurology, and cardiology. Nuclear medicine plays a pivotal role in detecting and managing diseases at a functional level, unlike traditional imaging methods that focus on structural changes. With plans to expand our services to include a Gamma Camera (SPECT) and a High-Dose Therapy Ward, our department aims to become a comprehensive centre for nuclear medicine, catering to both diagnostic and therapeutic needs.
Our department currently offers PET-CT imaging services, a powerful diagnostic tool that provides detailed functional and anatomical information in a single scan. PET-CT is particularly effective for cancer staging, monitoring treatment response, evaluating recurrent diseases, and radiation planning. The scan is also invaluable in neurological disorders such as epilepsy and dementia, as well as cardiac conditions to assess myocardial viability before revascularization.
Upcoming services include Gamma Camera (SPECT) imaging, which will enhance our ability to perform dynamic imaging for various organs, including the thyroid, bones, kidneys, and the heart. We are also developing a High-Dose Therapy Ward, where we will offer radionuclide therapies for thyroid cancer, neuroendocrine tumors, prostate cancer and other malignancies. Our department ensures a patient-centric approach with accurate diagnosis, effective therapies, and compassionate care.
We offer various therapeutic options that utilize radioactive substances to treat specific diseases:
Used for treating hyperthyroidism and thyroid cancers, it specifically targets and destroys thyroid tissue.
Effective for neuroendocrine tumors, it delivers targeted radiation to tumor cells, improving patient outcomes.
Used for metastatic prostate cancer, this therapy targets PSMA-expressing tumor cells, reducing tumor burden.
This therapy is used to relieve pain in patients with bone metastases by delivering targeted radiation to affected areas, improving quality of life.
A specialized therapy for liver cancers, delivering radiation directly to tumors while sparing surrounding tissue.
Used for staging, restaging, and monitoring of cancers such as lung, breast, lymphoma, and colorectal cancers. It detects metabolic activity in tumors for early diagnosis.
Helps in identifying epilepsy focus, diagnosing dementia, and assessing brain tumors. It provides functional imaging to study neurological conditions.
Evaluates myocardial viability and perfusion to assess ischemic heart disease, guiding treatment strategies like revascularization.
PET-CT detects sites of infection, inflammation, or abscesses, particularly useful in fever of unknown origin and prosthetic infections.
PET-CT provides precise tumor localization, enhancing the accuracy of radiation therapy planning and minimizing radiationexposure to healthy tissue.
A specialized scan used for detecting and staging prostate cancer by targeting PSMA-expressing tumor cells, ensuring accurate disease localization.
A highly specific imaging modality for neuroendocrine tumors, providing superior clarity and aiding in disease detection and treatment planning.
JNU is home to some of the most eminent doctors in the world, most of whom are pioneers in their respective arenas and are renowned for developing innovative and revolutionary procedures
Sr Consultant, Nuclear Medicine
MBBS, MD
Call
Appointments
Patient Support
Menu